Milind D. Chalishazar

MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition

Gürkan Mollaoglu, Matthew R. Guthrie, Stefanie Böhm et al. · Cancer Cell · 2017 · 607 citations · Full text

Medicine, Cancer Biology, Oncology +16

MYC Drives Temporal Evolution of Small Cell Lung Cancer Subtypes by Reprogramming Neuroendocrine Fate

Abbie S. Ireland, Alexi M. Micinski, David W. Kastner et al. · Cancer Cell · 2020 · 530 citations · Full text

Medicine, Cancer Biology, Oncology +16

Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

C. Allison Stewart, Carl M. Gay, Yuanxin Xi et al. · Nature Cancer · 2020 · 372 citations · Full text

Medicine, Cell Biology, Oncology +14

Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers

Fang Huang, Min Ni, Milind D. Chalishazar et al. · Cell Metabolism · 2018 · 199 citations · Full text

Medicine, Molecular Biology, Oncology +14

MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion

Milind D. Chalishazar, Sarah J. Wait, Fang Huang et al. · Clinical Cancer Research · 2019 · 182 citations

Medicine, Oncology, Pharmacology +17